BMY MEX Week ended 31 Jul 2026

Weekly Investor Report

Name: BMY weekly investor report
Creator: Sharemaestro
License: https://sharemaestro.com/data-license/

Bristol-Myers Squibb Company · Healthcare · Drug Manufacturers - General

Open interactive chart View report data

Latest close 1,126 MXN

4.7% latest week

Weekly setup

Mixed setup

The weekly trend is not active. Price is 10.9% above the Trend Line and sits at 99.7% of its 52-week range. The latest completed week returned 4.7%, after a 15.5% four-week move. The latest news-sentiment score is 61/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal.

Setup score 63 out of 100

Latest Close 1,126 MXN 31 Jul 2026

1W Return 4.7% latest completed week

4W Return 15.5% short-term follow-through

12W Return 16.4% quarterly tape

Trend Breadth 44.2% 23 of 52 weeks active

Volume Ratio 0.8x vs 13-week average

What is working

Price is above the Trend Line, keeping the weekly tape constructive.
Price is above Fair Value, showing premium demand versus the model.
Activity pressure is positive on the latest completed week.
Latest weekly return ranks in the strongest part of its sector group.

What could go wrong

The trend backdrop is inactive, so price action has not confirmed a constructive regime.
Activity pressure is weak, so confirmation is not yet broad enough.

What to watch next

Price is close to its 52-week high; watch for continuation or exhaustion.
Trend Line remains the key weekly regime level.
Activity pressure is the gauge to monitor for confirmation or fade.
A volume ratio above 1.5x would show stronger participation in the next move.

Price follow-through 4.7% Latest completed week; four-week move 15.5%. Indicator stack 24/71 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 61/100 24 relevant articles in the latest sentiment read.

01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 10.9% above the Trend Line and sits at 99.7% of its 52-week range. The latest completed week returned 4.7%, after a 15.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value

Price Trend Line Fair Value

Position in the 52-week range

Close Trend Fair

788.0 MXN 99.7% 1,127 MXN

Range location99.7%Shows where the latest close sits between the 52-week low and high.

Trend distance10.9%Price premium or discount versus the weekly Trend Line.

Fair-value gap17.8%Premium demand or model discount versus Sharemaestro Fair Value.

High-water gap-0.1%Distance from the latest 52-week high.

02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction

6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul

Up week Down week

Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2912-week average 0.41

12-week confirmation

Trend active3/12Active trend-backdrop weeks in the latest 12-week window.

Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.

Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.

Activity pressure0.29Current proprietary activity-pressure read.

Buy signals0Accumulation signal count in the latest 12 weeks.

Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 15.5% over four weeks, 16.4% over 12 weeks, and 32.7% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W4.7%

4W15.5%

12W16.4%

26W19.8%

52W32.7%

Active trend streak0 weeks

Active weeks in one year23

Trend breadth44.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership

Pressure0.51Latest activity-pressure read.

Pressure change147.0%Four-week change in activity pressure.

Leadership14.97Latest relative-leadership reading.

RS change3660.2%Four-week change in relative leadership.

04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment61/100

Weighted news tone is neutral across 24 relevant articles.

10 positive · 14 neutral · 0 negative

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal

06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.

Options expected move-Nearest-chain priced movement where available.

52-week drawdown-0.1%Distance below the 52-week high.

13-week volatility3.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

6 Feb 6 Mar 3 Apr 1 May 29 May 26 Jun 31 Jul

Weeks higher15 of 2611 weeks finished lower.

Best week+9.9%Week of 6 Feb.

Worst week-8.0%Week of 10 Apr.

Latest week+4.7%Week of 31 Jul.

Shape of recent returns

Strong gains6

Modest gains9

Flat weeks0

Modest losses8

Sharp losses3

Recent vol3.8%13-week weekly-return volatility.

Base vol3.8%52-week weekly-return volatility.

Up/down split28/24Count of positive and negative weeks in the 52-week window.

Average skew3.6% / -2.8%Average positive week versus average negative week.

07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

SectorMX Healthcare

4-week rank6 / 78

Group average-1.3%

Trend breadth28.2%

Trend28.2%active weekly trend signals

MD62.8%positive activity pressure

RS35.9%positive relative leadership

Four-week leaders

IQV · MEX23.0%INCY · MEX21.5%ILMN · MEX20.5%REGN · MEX17.1%BAYNN · MEX17.1%

IndustryMX Drug Manufacturers - General

4-week rank2 / 14

Group average1.5%

Trend breadth35.7%

Trend35.7%active weekly trend signals

MD71.4%positive activity pressure

RS64.3%positive relative leadership

Four-week leaders

BAYNN · MEX17.1%BMY · MEX15.5%NOVOBN · MEX5.9%GILD · MEX3.8%PFE · MEX3.3%

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape57/100

Trend, activity pressure, participation, and risk combine to a 57/100 tape read.

Indicator analysis31/100

Latest 12-week confirmation: trend 3/12, activity pressure 2/12, relative leadership 5/12.

Activity pressure 0.29; No reversal markers Factors50/100

No published factor snapshot is available yet.

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment61/100

Weighted news tone is neutral across 24 relevant articles.

Bristol Myers Squibb (BMY) Stock Shrugs Off Profit Surge And Patent Risk Insiders50/100

No recent insider transaction evidence is stored.

Earnings50/100

No stored earnings event is currently attached to this ticker.

Week	Close	Return	Trend Line	Fair Value	Pressure	Leadership	Volume	Trend
31 Jul 2026	1,126 MXN	4.7%	1,015 MXN	955.7 MXN	0.51	14.97	1.1K	Off
24 Jul 2026	1,075 MXN	1.9%	1,010 MXN	955.1 MXN	0.06	10.96	11.2K	Off
17 Jul 2026	1,055 MXN	5.0%	1,006 MXN	954.7 MXN	-0.45	8.56	2.2K	Off
10 Jul 2026	1,005 MXN	3.1%	1,004 MXN	954.9 MXN	-0.98	3.61	39	Off
3 Jul 2026	974.5 MXN	1.1%	1,002 MXN	955.1 MXN	-1.09	-0.42	5	Off
26 Jun 2026	963.6 MXN	4.8%	1,001 MXN	955.4 MXN	-1.17	-1.90	0	Off
19 Jun 2026	919.5 MXN	-4.1%	998.5 MXN	956.2 MXN	-1.12	-7.18	0	Off
12 Jun 2026	958.9 MXN	-2.0%	996.5 MXN	957.4 MXN	-0.99	-3.84	85	Off
5 Jun 2026	978.3 MXN	-2.6%	994.4 MXN	958.4 MXN	-0.96	0.49	24	Off
29 May 2026	1,004 MXN	-0.2%	990.7 MXN	959.3 MXN	-0.90	-0.69	61	On
22 May 2026	1,006 MXN	3.6%	985.5 MXN	960.2 MXN	-0.73	-0.18	68	On
15 May 2026	971.3 MXN	0.4%	979.3 MXN	961.0 MXN	-0.61	-3.30	764	On
8 May 2026	967.4 MXN	-7.9%	973.8 MXN	962.2 MXN	-0.35	-6.42	3.2K	On
1 May 2026	1,050 MXN	2.9%	969.1 MXN	963.7 MXN	-0.20	4.29	320	On

How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.